Matches in SemOpenAlex for { <https://semopenalex.org/work/W2937465963> ?p ?o ?g. }
- W2937465963 endingPage "312" @default.
- W2937465963 startingPage "305" @default.
- W2937465963 abstract "Purpose of review A variety of high-efficacy disease-modifying therapies (DMTs) are available for the treatment of multiple sclerosis (MS). After evaluation and approval by regulatory agencies, DMTs are likely to be administered to patients whose characteristics differ from those enrolled in clinical trials. This may contribute to the emergence of unexpected adverse events observed in the real-world setting. Higher age may be a relevant factor that could change the benefit–risk balance of DMTs, as it may associate with lower efficiency and higher frequency of adverse events. Recent findings The absolute and relative number of patients with MS who reach the age of 55 and higher increases. Growing evidence demonstrates lower efficacy of DMTs in older persons with MS. Specific risks during DMTs for MS, such as the risk of developing progressive multifocal leukoencephalopathy (PML) or the outcome following PML, have been associated with age. It is hypothesized that age-related and therapy-induced alterations to the immune system may have (super)additive effects, resulting in an acceleration of physiological immunosenescence and inflamm-aging. Summary In this article, we review the risks of high-efficacy DMTs in MS with a specific focus on age-related efficacy and risks, including opportunistic infections, malignancies, and autoimmune reactions." @default.
- W2937465963 created "2019-04-25" @default.
- W2937465963 creator A5006315449 @default.
- W2937465963 creator A5032841555 @default.
- W2937465963 creator A5043553934 @default.
- W2937465963 creator A5054902961 @default.
- W2937465963 creator A5063615479 @default.
- W2937465963 creator A5075919533 @default.
- W2937465963 creator A5083946982 @default.
- W2937465963 date "2019-06-01" @default.
- W2937465963 modified "2023-10-11" @default.
- W2937465963 title "Age and the risks of high-efficacy disease modifying drugs in multiple sclerosis" @default.
- W2937465963 cites W105081038 @default.
- W2937465963 cites W1486303545 @default.
- W2937465963 cites W1916685456 @default.
- W2937465963 cites W1944603265 @default.
- W2937465963 cites W1970751485 @default.
- W2937465963 cites W1971907346 @default.
- W2937465963 cites W1981265441 @default.
- W2937465963 cites W1997412308 @default.
- W2937465963 cites W2016256318 @default.
- W2937465963 cites W2074738783 @default.
- W2937465963 cites W2092874537 @default.
- W2937465963 cites W2103758700 @default.
- W2937465963 cites W2104948944 @default.
- W2937465963 cites W2139204856 @default.
- W2937465963 cites W2143322657 @default.
- W2937465963 cites W2143771994 @default.
- W2937465963 cites W2148422519 @default.
- W2937465963 cites W2148766438 @default.
- W2937465963 cites W2151340435 @default.
- W2937465963 cites W2158202057 @default.
- W2937465963 cites W2166553309 @default.
- W2937465963 cites W2169676611 @default.
- W2937465963 cites W2191830820 @default.
- W2937465963 cites W2337235966 @default.
- W2937465963 cites W2489130503 @default.
- W2937465963 cites W2518307266 @default.
- W2937465963 cites W2548044085 @default.
- W2937465963 cites W2561881161 @default.
- W2937465963 cites W2566402516 @default.
- W2937465963 cites W2584732326 @default.
- W2937465963 cites W2733043067 @default.
- W2937465963 cites W2741349427 @default.
- W2937465963 cites W2756612472 @default.
- W2937465963 cites W2767362256 @default.
- W2937465963 cites W2783874580 @default.
- W2937465963 cites W2790223348 @default.
- W2937465963 cites W2791329038 @default.
- W2937465963 cites W2792949361 @default.
- W2937465963 cites W2793282252 @default.
- W2937465963 cites W2793885330 @default.
- W2937465963 cites W2800194662 @default.
- W2937465963 cites W2802030355 @default.
- W2937465963 cites W2888206660 @default.
- W2937465963 cites W2889214655 @default.
- W2937465963 cites W2890515892 @default.
- W2937465963 cites W2894197160 @default.
- W2937465963 cites W2897587086 @default.
- W2937465963 cites W2901480767 @default.
- W2937465963 cites W2907269180 @default.
- W2937465963 cites W2911658427 @default.
- W2937465963 cites W2914720734 @default.
- W2937465963 cites W2916478209 @default.
- W2937465963 cites W2926747273 @default.
- W2937465963 cites W4211090999 @default.
- W2937465963 doi "https://doi.org/10.1097/wco.0000000000000701" @default.
- W2937465963 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30985373" @default.
- W2937465963 hasPublicationYear "2019" @default.
- W2937465963 type Work @default.
- W2937465963 sameAs 2937465963 @default.
- W2937465963 citedByCount "52" @default.
- W2937465963 countsByYear W29374659632019 @default.
- W2937465963 countsByYear W29374659632020 @default.
- W2937465963 countsByYear W29374659632021 @default.
- W2937465963 countsByYear W29374659632022 @default.
- W2937465963 countsByYear W29374659632023 @default.
- W2937465963 crossrefType "journal-article" @default.
- W2937465963 hasAuthorship W2937465963A5006315449 @default.
- W2937465963 hasAuthorship W2937465963A5032841555 @default.
- W2937465963 hasAuthorship W2937465963A5043553934 @default.
- W2937465963 hasAuthorship W2937465963A5054902961 @default.
- W2937465963 hasAuthorship W2937465963A5063615479 @default.
- W2937465963 hasAuthorship W2937465963A5075919533 @default.
- W2937465963 hasAuthorship W2937465963A5083946982 @default.
- W2937465963 hasConcept C126322002 @default.
- W2937465963 hasConcept C177713679 @default.
- W2937465963 hasConcept C187212893 @default.
- W2937465963 hasConcept C197934379 @default.
- W2937465963 hasConcept C203014093 @default.
- W2937465963 hasConcept C2776036978 @default.
- W2937465963 hasConcept C2779056147 @default.
- W2937465963 hasConcept C2779134260 @default.
- W2937465963 hasConcept C2780640218 @default.
- W2937465963 hasConcept C2780644213 @default.
- W2937465963 hasConcept C535046627 @default.
- W2937465963 hasConcept C71924100 @default.
- W2937465963 hasConcept C8891405 @default.